This review describes the pharmacologic profiles and clinical effects of various beta-blockers to assist primary care physicians in selecting the appropriate agent for hypertensive patients.
Answers are grounded in this paper and cite their sources.
May guide beta-blocker selection in hypertension via profiles; leaves open need for comparative trials to refine choices.
PreviewAll of the currently available beta-adrenergic blocking agents lower blood pressure. However, because of differences in pharmacologic properties, one beta blocker may be safer and more effective than another in a particular hypertensive patient. In this article, Dr Amadio and his coauthors describe these agents' pharmacologic profiles and clinical effects in an effort to help the primary care physician select the best drug for each hypertensive patient.
No takes yet. Share an insight, caveat, or question.
Amadio et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: